Cargando…
The Human Positive Cofactor 4 is a Promising Chemotherapeutic Target in Lung Adenocarcinoma
Reduced sensitivity to chemotherapeutic drugs is almost inevitable in lung adenocarcinoma patients. Thus, understanding the relevant mechanisms is urgent. Positive cofactor 4 (PC4) was at first revealed to be a coactivator of basal transcription. Previous research has shown that PC4 participates in...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664520/ https://www.ncbi.nlm.nih.gov/pubmed/34899911 http://dx.doi.org/10.1155/2021/9958483 |